Source: Zolmax News

Pivotal Therapeutics: Osmotica Pharmaceuticals (NASDAQ:OSMT) and Pivotal Therapeutics (NASDAQ:PVTTF) Head to Head Survey

Osmotica Pharmaceuticals (NASDAQ:OSMT) and Pivotal Therapeutics (OTCMKTS:PVTTF) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, profitability and analyst recommendations. Risk & Volatility Osmotica Pharmaceuticals has a beta of 3.45, indicating that its share price is [...]

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
CEO Avatar

President & CEO

Rachelle MacSweeney

CEO Approval Rating

70/100

Read more